Treatment of Raynaud's phenomenon with ketanserin.
D000293:Adolescent; D006801:Humans; D007650:Ketanserin; D007871:Leg Ulcer / Q000188:drug therapy*; D008297:Male; D010880:Piperidines / Q000627:therapeutic use*; D012595:Scleroderma, Systemic / Q000150:complications*
D010880:Piperidines; D007650:Ketanserin